Clinical trial
Revatio Special Investigation - Investigation for Long-Term Use of Revatio in Pediatric Patients
NCT03364244 is registered in ClinicalTrials.gov with Viatris Pharmaceuticals Japan Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Revatio Special Investigation - Investigation for Long-Term Use of Revatio in Pediatric Patients
- Lead sponsor
- Viatris Pharmaceuticals Japan Inc
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2017
- Completion date
- August 30, 2022
- Enrollment
- 1,023 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.